Who owns ANEBULO PHARMACEUTICALS INC?
- Ticker: ANEB
- CUSIP Number: 034569103
Tip: Access positions for across all investors
Analyze quarterly positions in Anebulo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Anebulo Pharmaceuticals stock
Who bought or sold ANEBULO PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| 22NW | 5.4M | $15M | 0% | Mar 2024 |
|
| LVW Advisors | 642k | $1.8M | 0% | Mar 2024 |
|
| Nantahala Capital Management | 511k | $1.5M | 0% | Mar 2024 |
|
| Morgan Stanley | 399k | $1.1M | 100% | Mar 2024 |
|
| Ikarian Capital | 158k | $453k | 0% | Mar 2024 |
|
| Vanguard Group | 154k | $441k | 0% | Mar 2024 |
|
| Susquehanna International | 25k | $73k | 100% | Mar 2024 |
|
| Geode Capital Management | 23k | $65k | 100% | Mar 2024 |
|
| Boothbay Fund Management | 19k | $55k | 0% | Mar 2024 |
|
| Tower Research Capital | 5.1k | $15k | -75% | Mar 2024 |
|
| BlackRock | 4.0k | $12k | -3% | Mar 2024 |
|
| UBS Group | 144.00 | $413.006400 | 100% | Mar 2024 |
|
| Wells Fargo & Company | 62.00 | $178.002000 | 2% | Mar 2024 |
|
| Royal Bank of Canada | 38.00 | $0 | -46% | Mar 2024 |
|
| Jpmorgan Chase & Co | 9.00 | $26.000100 | 100% | Mar 2024 |
|
Who sold out of Anebulo Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Mangrove Partners | Sep 2023 | 399k | $1.2M |
| Landscape Capital Management | Dec 2023 | 15k | $36k |
| ADAR1 Capital Management | Dec 2023 | 1.2k | $2.9k |